X-55009056-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000032.5(ALAS2):c.*124C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00395 in 905,640 control chromosomes in the GnomAD database, including 34 homozygotes. There are 1,051 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 3 hom., 188 hem., cov: 23)
Exomes 𝑓: 0.0040 ( 31 hom. 863 hem. )
Consequence
ALAS2
NM_000032.5 3_prime_UTR
NM_000032.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.83
Genes affected
ALAS2 (HGNC:397): (5'-aminolevulinate synthase 2) The product of this gene specifies an erythroid-specific mitochondrially located enzyme. The encoded protein catalyzes the first step in the heme biosynthetic pathway. Defects in this gene cause X-linked pyridoxine-responsive sideroblastic anemia. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
APEX2 (HGNC:17889): (apurinic/apyrimidinic endodeoxyribonuclease 2) Apurinic/apyrimidinic (AP) sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. AP sites are pre-mutagenic lesions that can prevent normal DNA replication so the cell contains systems to identify and repair such sites. Class II AP endonucleases cleave the phosphodiester backbone 5' to the AP site. This gene encodes a protein shown to have a weak class II AP endonuclease activity. Most of the encoded protein is located in the nucleus but some is also present in mitochondria. This protein may play an important role in both nuclear and mitochondrial base excision repair. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-55009056-G-A is Benign according to our data. Variant chrX-55009056-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 913522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00368 (414/112422) while in subpopulation NFE AF= 0.00248 (132/53323). AF 95% confidence interval is 0.00213. There are 3 homozygotes in gnomad4. There are 188 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALAS2 | NM_000032.5 | c.*124C>T | 3_prime_UTR_variant | 11/11 | ENST00000650242.1 | NP_000023.2 | ||
APEX2 | NM_014481.4 | c.*1621G>A | 3_prime_UTR_variant | 6/6 | ENST00000374987.4 | NP_055296.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APEX2 | ENST00000374987.4 | c.*1621G>A | 3_prime_UTR_variant | 6/6 | 1 | NM_014481.4 | ENSP00000364126 | P1 | ||
ALAS2 | ENST00000650242.1 | c.*124C>T | 3_prime_UTR_variant | 11/11 | NM_000032.5 | ENSP00000497236 | P1 | |||
ALAS2 | ENST00000396198.7 | c.*124C>T | 3_prime_UTR_variant | 11/11 | 5 | ENSP00000379501 | ||||
ALAS2 | ENST00000335854.8 | downstream_gene_variant | 2 | ENSP00000337131 |
Frequencies
GnomAD3 genomes AF: 0.00368 AC: 414AN: 112368Hom.: 3 Cov.: 23 AF XY: 0.00545 AC XY: 188AN XY: 34520
GnomAD3 genomes
AF:
AC:
414
AN:
112368
Hom.:
Cov.:
23
AF XY:
AC XY:
188
AN XY:
34520
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00398 AC: 3160AN: 793218Hom.: 31 Cov.: 12 AF XY: 0.00410 AC XY: 863AN XY: 210654
GnomAD4 exome
AF:
AC:
3160
AN:
793218
Hom.:
Cov.:
12
AF XY:
AC XY:
863
AN XY:
210654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00368 AC: 414AN: 112422Hom.: 3 Cov.: 23 AF XY: 0.00544 AC XY: 188AN XY: 34584
GnomAD4 genome
AF:
AC:
414
AN:
112422
Hom.:
Cov.:
23
AF XY:
AC XY:
188
AN XY:
34584
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 31, 2018 | - - |
X-linked sideroblastic anemia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at